| __timestamp | Novartis AG | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 9086000000 | 22223073 |
| Thursday, January 1, 2015 | 8935000000 | 6966842 |
| Friday, January 1, 2016 | 9039000000 | 9000499 |
| Sunday, January 1, 2017 | 8972000000 | 13741186 |
| Monday, January 1, 2018 | 9074000000 | 19040000 |
| Tuesday, January 1, 2019 | 9402000000 | 23559000 |
| Wednesday, January 1, 2020 | 8980000000 | 31931000 |
| Friday, January 1, 2021 | 9540000000 | 44981000 |
| Saturday, January 1, 2022 | 9996000000 | 54234000 |
| Sunday, January 1, 2023 | 11371000000 | 63806000 |
| Monday, January 1, 2024 | 10022000000 |
Data in motion
In the ever-evolving pharmaceutical landscape, innovation is the key to staying ahead. Over the past decade, Novartis AG has consistently outpaced Viking Therapeutics, Inc. in research and development (R&D) spending. From 2014 to 2023, Novartis's R&D expenses have surged by approximately 25%, peaking at over $11 billion in 2023. In contrast, Viking Therapeutics, while showing growth, has invested significantly less, with their R&D expenses reaching just over $63 million in the same year.
This stark difference highlights Novartis's commitment to innovation, investing nearly 180 times more than Viking Therapeutics in 2023 alone. Such investment is crucial for developing groundbreaking treatments and maintaining a competitive edge. As the industry continues to evolve, the disparity in R&D spending underscores the varying strategies of these two companies in their quest for innovation.
Research and Development Expenses Breakdown: Eli Lilly and Company vs Viking Therapeutics, Inc.
R&D Insights: How Novartis AG and Blueprint Medicines Corporation Allocate Funds
Research and Development Expenses Breakdown: Novartis AG vs Halozyme Therapeutics, Inc.
Research and Development Expenses Breakdown: Novartis AG vs Pharming Group N.V.
Research and Development Expenses Breakdown: Novartis AG vs Ultragenyx Pharmaceutical Inc.
R&D Spending Showdown: Regeneron Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.
Bio-Techne Corporation vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Jazz Pharmaceuticals plc vs Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: Halozyme Therapeutics, Inc. vs Viking Therapeutics, Inc.
Comparing Innovation Spending: Viking Therapeutics, Inc. and Soleno Therapeutics, Inc.
Comparing Innovation Spending: Viking Therapeutics, Inc. and Wave Life Sciences Ltd.